Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)
Eligible age
18–70 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this research is to examine the effects that functional electrical stimulation (FES) therapy has on the way the arms, brain and spinal cord work. The study team wants to understand what recovery looks like in persons with a spinal cord injury (SCI) or peripheral nerve injury (PNI) using the MyndMove (MyndTec Inc., Ontario, Canada) therapy system. This type of therapy uses stimulation to help people with SCI and other neurological conditions to perform common tasks, work out, or strengthen muscles.
Sponsor: University of Miami
You may qualify if…
- ✓ 1\. Neurological Injury:
- ✓ 1. Traumatic spinal cord injury (SCI): neurological level at or above T1 spinal cord level; AIS A, B, C or D impairment grade
- ✓ Group 1 (Acute SCI): Deemed medically stable by medical practitioner, less than 6 months post-injury.
- ✓ Group 2 (Chronic SCI): More than 6 months post-injury.
- ✓ or
- ✓ 2. Peripheral nerve injury (PNI), with or without SCI, who are pre- or post- upper extremity (UE) nerve transfer surgery
- ✓ Group 3 (Acute Pre- or Post-UE nerve transfer surgery): Deemed medically stable and safe/appropriate to participate in MyndMove UE FES therapy intervention by referring neurosurgeon within 6 months pre- or post-UE nerve transfer surgery.
- ✓ Group 4 (Chronic Post-UE nerve transfer surgery): Deemed medically stable and safe/appropriate to participate in MyndMove UE FES therapy intervention by referring neurosurgeon 6 months or more post-UE nerve transfer surgery.
You may not qualify if…
- ✕ 1. Traumatic brain injury, stroke, multiple sclerosis, or other disorders that could affect neuromotor function.
- ✕ 2. Severe spasticity that could prevent the study protocol as determined by the investigator.
- ✕ 3. Major executive dysfunction, dementia, depression, neurocognitive impairments, or other major medical co-morbidities.
- ✕ 4. Has contraindications for transcutaneous stimulation using FES such as breakdown of skin in the area that will come into contact with electrodes, thrombosis, or skin disease
- ✕ 5. Poorly managed autonomic dysreflexia that could be triggered by FES.
- ✕ 6. Unhealed upper extremity fracture, contracture, or pressure sore.
- ✕ 7. Implanted neurostimulator (e.g., deep brain stimulation (DBS), epidural/subdural, vagal nerve stimulation (VNS))
- ✕ 8. Cardiac pacemaker or intracardiac lines.
Where it's recruiting
Miami
Source: ClinicalTrials.gov · NCT06672458 · last updated 2026-04-23